Clinical Implications of the Amyloidogenic V122I Transthyretin Variant in the General Population. Kozlitina J, Garg S, Drazner MH, Matulevicius SA, et al. J Card Fail 2022;28:403-414.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Kozlitina J, Garg S, Drazner MH, Matulevicius SA, et al. Clinical Implications of the Amyloidogenic V122I Transthyretin Variant in the General Population. J Card Fail 2022;28:403-414.
PMID: 34634447